skip to Main Content



We invite you to join online for our presentation and schedule some time to connect with us to receive answers to all your questions about the clinical oncology landscape in Canada.

Nov 17


Whether you’re looking to expand an existing oncology trial due to slow recruitment or are planning to include Canada in an upcoming trial, our Reverse Feasibility Program will connect you with sites that have proven they can deliver the results you’re looking for.

Here’s what the VP of Clinical Operations from one U.S. biotech had to say about his recent experience in Canada.

“Having recently expanded our Phase II trial to Canada through the Reverse Feasibility Program, we found that Canadian investigators were highly engaged in our studies. Their participation resulted in having our FPI (First Patient In) within 3 weeks and greatly contributed to being able to meet our enrolment objectives four months ahead of schedule.”

Call Julie Martin today at (514) 815-7066 or fill out the form on the right to schedule a Discovery Meeting during the conference to discuss your expansion plans.

Request a Meeting

  • (###) ###-####
  • This field is for validation purposes and should be left unchanged.

Back To Top
×Close search